Rebecca Franklin
Family · Grenada, MSNPI 1902369457
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 107 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 22 manufacturers reported payments, led by AbbVie at 32.6% of the total. Reporting peaked in 2021 at $597 and has fallen 97.8% since, to $13 in 2024.
Across 107 payments — averaging $13.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$464
- AstraZeneca$144
- Bayer$123
- Novartis$103
- Lilly USA, LLC$89
- Biohaven Pharmaceuticals, Inc.$68
- plus $434 from 16 others
What the payments were for
- Food & beverage$1,426100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 43 | $464 |
| AstraZeneca | 9 | $144 |
| Bayer | 8 | $123 |
| Novartis | 7 | $103 |
| Lilly USA, LLC | 6 | $89 |
| Biohaven Pharmaceuticals, Inc. | 5 | $68 |
| Novo Nordisk | 4 | $56 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $49 |
| Esperion Therapeutics, Inc. | 3 | $41 |
| Amgen | 2 | $33 |
| GSK | 2 | $33 |
| Pfizer | 2 | $32 |
| Ironwood Pharmaceuticals, Inc | 2 | $30 |
| Kowa Pharmaceuticals America, Inc. | 2 | $27 |
| Boehringer Ingelheim | 2 | $25 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| Eisai Inc. | 1 | $17 |
| Amarin Pharma, Inc. | 1 | $17 |
| Genentech USA, Inc. | 1 | $14 |
| Mimedx Group, Inc. | 1 | $13 |
| Medtronic | 1 | $13 |
| Boston Scientific | 1 | $12 |
How this compares
$1,426 in reported general payments places this provider in the 75th percentile of 3,007 family providers in Mississippi.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 32 | $773 |
| Fluconazole | 17 | $68 |
| Metronidazole | 14 | $50 |
Paid to pharmacies, not to this prescriber.
Other family in Grenada
- Dodie McGeeRaymond$772K
- Gina BurgeJackson$237K
- Christy DavisJackson$208K
- Maranda EversollFlowood$197K
- Dana DelaskiJackson$158K
- Kristin CarrollJackson$158K
- Shannon FryeryOxford$127K
- Nativel CollinsMantachie$73K
- Ashley CocilovaFlowood$72K
- Andrea WallaceOlive Branch$50K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.